Marker Therapeutics

+$0.04 (+2.11%) As of 4:14 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

CEO
Peter L. Hoang
Employees
44
Headquarters
Houston, Texas
Founded
1991

MRKR Key Statistics

Market Cap
154.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
263.28K
High Today
$1.86
Low Today
$1.78
Open Price
$1.78
Volume
185.92K
52 Week High
$3.77
52 Week Low
$1.32

MRKR Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure